ResMed Inc. (RMD) vs West Pharmaceutical Services, Inc. (WST)
RMD leads on 16 of 17 compared metrics.
A side-by-side comparison of ResMed Inc. and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 20, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
RMD
ResMed Inc.
$198.61HealthcareDelayed quote: Jul 20, 2026, 4:00 PM EDT
WST
West Pharmaceutical Services, Inc.
$352.32HealthcareAt close: Jul 20, 2026, 4:00 PM ET
Total return — RMD vs WST
growth of $100 · dividends reinvested · last 30yRMD +22573.5%WST +8080.9%RMD compounded faster
RMD WST
RMD vs WST: by the numbers
- •RMD is the larger company ($28.81B vs $24.89B market cap).
- •RMD trades at the lower earnings multiple (19.21 vs 47.04 P/E).
- •RMD converts more revenue to profit (27.44% vs 16.85% net margin).
- •RMD grew revenue faster over the past five years (12.37% vs 6.72% CAGR).
- •RMD pays the higher dividend yield (1.21% vs 0.25%).
Which is better, RMD or WST?
Metric tally: RMD 16 · WST 1It depends on what you're optimizing for:
ValueRMD(lower P/E)
GrowthRMD(faster 5Y revenue CAGR)
IncomeRMD(higher dividend yield)
QualityRMD(higher ROIC)
Metrics side by side
Valuation
| Metric | RMD | WST |
|---|---|---|
| P/E ratio | 19.21● | 47.04 |
| Forward P/E | 17.88● | 40.88 |
| P/S ratio | 5.27● | 7.92 |
| P/B ratio | 4.50● | 8.53 |
| PEG ratio | 0.72● | 33.99 |
| EV / EBITDA | 13.19● | 30.07 |
| FCF yield | 5.99%● | 1.80% |
Profitability
| Metric | RMD | WST |
|---|---|---|
| Gross margin | 61.69%● | 36.24% |
| Operating margin | 34.28%● | 20.67% |
| Net margin | 27.44%● | 16.85% |
| ROE | 23.41%● | 18.15% |
| ROIC | 19.56%● | 13.62% |
Dividends
| Metric | RMD | WST |
|---|---|---|
| Dividend yield | 1.21%● | 0.25% |
| Payout ratio | 25.13% | 12.74% |
Growth (annualized)
| Metric | RMD | WST |
|---|---|---|
| Revenue CAGR (5Y) | 12.37%● | 6.72% |
| EPS CAGR (5Y) | 17.25%● | 7.85% |
| FCF CAGR (5Y) | 18.98%● | 8.32% |
| Total return CAGR (5Y) | -4.05% | -0.87%● |
Frequently asked
- Which is better, RMD or WST?
- It depends on your goal. value: RMD (lower P/E); growth: RMD (faster 5Y revenue CAGR); income: RMD (higher dividend yield); quality: RMD (higher ROIC). Across all compared metrics, RMD leads 16 to 1.
- Is RMD or WST cheaper?
- On trailing earnings, RMD is cheaper: RMD trades at a 19.21 P/E and WST at 47.04.
- Which has grown faster, RMD or WST?
- Over the past five years, RMD grew revenue faster — RMD at a 12.37% CAGR versus WST at 6.72%.
- Does RMD or WST pay a bigger dividend?
- RMD yields 1.21% and WST yields 0.25% based on trailing dividends and the latest price.
- Is RMD or WST more profitable?
- RMD runs the higher net margin — RMD at 27.44% versus WST at 16.85%.
- Which has been the better investment, RMD or WST?
- Over the past 10-year, WST delivered the higher annualized total return — RMD at 12.90% versus WST at 16.62%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ResMed P/E ratioWest Pharmaceutical Services P/E ratioResMed dividend yieldWest Pharmaceutical Services dividend yieldResMed ROEWest Pharmaceutical Services ROEResMed operating marginWest Pharmaceutical Services operating marginResMed revenue growthWest Pharmaceutical Services revenue growthResMed free cash flowWest Pharmaceutical Services free cash flow
ResMed & West Pharmaceutical Services appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 20, 2026.